全文获取类型
收费全文 | 5354篇 |
免费 | 198篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 92篇 |
妇产科学 | 81篇 |
基础医学 | 750篇 |
口腔科学 | 146篇 |
临床医学 | 298篇 |
内科学 | 1465篇 |
皮肤病学 | 52篇 |
神经病学 | 332篇 |
特种医学 | 185篇 |
外科学 | 984篇 |
综合类 | 42篇 |
预防医学 | 165篇 |
眼科学 | 51篇 |
药学 | 278篇 |
中国医学 | 38篇 |
肿瘤学 | 589篇 |
出版年
2024年 | 7篇 |
2023年 | 25篇 |
2022年 | 55篇 |
2021年 | 100篇 |
2020年 | 56篇 |
2019年 | 64篇 |
2018年 | 87篇 |
2017年 | 70篇 |
2016年 | 66篇 |
2015年 | 88篇 |
2014年 | 128篇 |
2013年 | 146篇 |
2012年 | 297篇 |
2011年 | 337篇 |
2010年 | 170篇 |
2009年 | 181篇 |
2008年 | 288篇 |
2007年 | 352篇 |
2006年 | 348篇 |
2005年 | 405篇 |
2004年 | 382篇 |
2003年 | 391篇 |
2002年 | 402篇 |
2001年 | 46篇 |
2000年 | 57篇 |
1999年 | 92篇 |
1998年 | 105篇 |
1997年 | 104篇 |
1996年 | 94篇 |
1995年 | 74篇 |
1994年 | 49篇 |
1993年 | 52篇 |
1992年 | 38篇 |
1991年 | 32篇 |
1990年 | 39篇 |
1989年 | 39篇 |
1988年 | 35篇 |
1987年 | 28篇 |
1986年 | 33篇 |
1985年 | 24篇 |
1984年 | 24篇 |
1983年 | 24篇 |
1982年 | 15篇 |
1981年 | 23篇 |
1980年 | 18篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 12篇 |
1976年 | 11篇 |
1975年 | 10篇 |
排序方式: 共有5577条查询结果,搜索用时 0 毫秒
991.
992.
993.
Osamu Watanabe Ikuro Maruyama Kimiyoshi Arimura Isao Kitajima Hitoshi Arimura Mitsuya Hanatani Katsuhiko Matsuo Takayo Arisato Mitsuhiro Osame 《Muscle & nerve》1998,21(11):1390-1397
Crow–Fukase or POEMS syndrome of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes is a rare multisystem disorder of obscure pathogenesis that is associated with microangiopathy, neovascularization, and accelerated vasopermeability. We examined the levels of the vascular endothelial growth factor/vascular permeability factor (VEGF) in the serum and cerebrospinal fluid (CSF) from 10 patients with this syndrome. Serum VEGF levels were about 15–30 times those in control subjects or patients with Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and other neurological disorders. The CSF VEGF levels, however, were similar to those found in GBS and CIDP. Elevated VEGF levels in the serum decreased in 7 patients with Crow–Fukase syndrome after conventional therapy. The principal isoform of VEGF in Crow–Fukase syndrome was VEGF165. Elevated VEGF was independent of M-protein. Our results suggest that the overproduction of VEGF is important in the pathogenesis of this disorder. © 1998 John Wiley & Sons, Inc. Muscle Nerve 21: 1390–1397, 1998 相似文献
994.
995.
Ronald A. Lubet Vernon E. Steele Isao Eto M. Margaret Juliana Gary J. Kelloff Clinton J. Grubbs 《International journal of cancer. Journal international du cancer》1997,72(1):95-101
The chemopreventive efficacy of N-acetyl-L-cysteine (NAC), anethole trithione, miconazole and phenethylisothiocyanate (PEITC), each of which would be expected to alter carcinogen metabolism, was examined in the dimethylbenzanthracene (DMBA) mammary carcinogenesis model. In this protocol, animals were exposed to non-toxic doses of the chemopreventives in the diet beginning 7 days prior to DMBA administration and then continuously throughout the duration of the assay (100 days post carcinogen). Miconazole, an antifungal agent with relatively broad inhibitory activity toward a variety of cytochromes P450, increased mammary tumor latency, decreased tumor incidence at the highest dose and decreased tumor multiplicity up to 60%. Anethole trithione, a substituted dithiolthione and an analog of the relatively broad-spectrum chemopreventive oltipraz, was administered in the diet and significantly inhibited mammary cancer multiplicity but not cancer incidence. NAC, an antimucolytic agent, failed to inhibit DMBA-induced mammary tumorigenesis. Surprisingly, treatment with DMBA plus PEITC, a potent inhibitor of cytochrome P450 2E1, actually increased the multiplicity of tumors relative to that observed with DMBA alone. Int. J. Cancer 72:95–101, 1997. © 1997 Wiley-Liss Inc. 相似文献
996.
Kimiyoshi Arimura Osamu Watanabe Isao Kitajima Masahito Suehara Seiichi Minato Yoshito Sonoda Itsuro Higuchi Satoshi Takenaga Ikuro Maruyama Mitsuhiro Osame 《Muscle & nerve》1997,20(3):299-305
We investigated the pathophysiology of nerve hyperexcitability in a patient with Isaacs' syndrome, who had typical clinical and electromyographic features and responded to plasma exchange. Immunoblotting and immunohistochemistry studies showed that antibodies from this patient reacted with the lysate at a neuronal cell line (PC12). In Western blots, constituents of the patient's serum, particularly immunoglobulin M, reacted with proteins of approximately 50 and 18 kDa, whereas the control serum did not. A cross-linking study with alpha-dendrotoxin (7 kDa) showed a 57 kDa protein-peptide complex. Immunohistochemistry showed that the patient's serum reacted with PC12 cells and human intramuscular nerve axons. Our findings indicate that in Isaac's syndrome nerve hyperexcitability is the result of the immunological involvement of the voltage-dependent potassium channels located along the distal motor nerve or at the nerve terminal. © 1997 John Wiley & Sons, Inc. Muscle Nerve, 20, 299–305, 1997. 相似文献
997.
998.
Satoshi Mochida Nobuaki Nakayama Akio Ido Kazuaki Inoue Takuya Genda Yasuhiro Takikawa Isao Sakaida Shuji Terai Osamu Yokosuka Masahito Shimizu Hajime Takikawa 《Hepatology research》2018,48(4):219-224
To establish diagnostic criteria for acute‐on‐chronic liver failure (ACLF) in Japan, the Intractable Hepato‐Biliary Disease Study Group of Japan undertook a multicenter pilot survey for patients fulfilling the Asian Pacific Association for the Study of the Liver (APASL), Association for the Study of the Liver–Chronic Liver Failure (EASL‐Clif) Consortium, or Chinese Medical Association (CMA) diagnostic criteria for ACLF. The APASL criteria were suitable for screening Japanese patients with ACLF when patients whose conditions were triggered by gastrointestinal bleeding were included within the disease entity, and the EASL‐Clif Consortium criteria were useful for classifying the severity of the patients’ conditions. Based on these observations, the Study Group proposed the following diagnostic criteria for ACLF in Japan: patients with cirrhosis and a Child–Pugh score of 5–9 should be diagnosed as having ACLF when a deterioration of liver function (serum bilirubin level ≥5.0 mg/dL and prothrombin time value ≤40% of the standardized values and/or international normalization rate ≥1.5) caused by severe liver damage develops within 28 days after acute insults, such as alcohol abuse, bacterial infection, gastrointestinal bleeding, or the exacerbation of underlying liver diseases. The severities of the patients can be classified into four grades depending on the extent of the deterioration in organ functions, including kidney, cerebral, blood coagulation, circulatory and respiratory functions, as well as liver function. The usefulness of these novel criteria should be validated prospectively in a large‐scale cohort in the future. 相似文献
999.
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III,multicenter, randomized,evaluator‐blinded,active‐controlled trial and a phase III,multicenter, open trial 下载免费PDF全文
Kazuyuki Suzuki Ryujin Endo Yasuhiro Takikawa Fuminori Moriyasu Yutaka Aoyagi Hisataka Moriwaki Shuji Terai Isao Sakaida Yoshiyuki Sakai Shuhei Nishiguchi Toru Ishikawa Hitoshi Takagi Atsushi Naganuma Takuya Genda Takafumi Ichida Koichi Takaguchi Katsuhiko Miyazawa Kiwamu Okita 《Hepatology research》2018,48(6):411-423
1000.
The aim of the present review was to clarify the association between obstructive sleep apnea (OSA) and type 2 diabetes, and discuss the therapeutic role of continuous positive airway pressure (CPAP) in type 2 diabetes. OSA patients are more likely than non‐OSA populations to develop type 2 diabetes, while more than half of type 2 diabetes patients suffer from OSA. Similar to Western countries, in the East Asian population, the association between these two disorders has also been reported. CPAP is the primary treatment for OSA, but the effect of CPAP on comorbid diabetes has not been established. CPAP improved glucose metabolism determined by the oral glucose tolerance test in OSA patients, and several studies have shown that CPAP improves insulin resistance, particularly in obese populations undergoing long‐term CPAP. Diabetes is associated with other sleep‐related manifestations as well, such as snoring and excessive daytime sleepiness. Snoring is associated with the development of diabetes, and excessive daytime sleepiness appears to modify insulin resistance. Well‐designed studies are required to clarify the therapeutic effect of CPAP on diabetes. As both diabetes and OSA lead to cardiovascular disease, clinicians and healthcare professionals should be aware of the association between diabetes and OSA, and should take CPAP and health‐related behaviors into consideration when treating patients with diabetes and/or OSA. 相似文献